Is IMGN or DIVO a better dividend investment in 2026?

IMGN currently yields 6.40% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: DIVO offers higher current income.

What is the dividend yield difference between IMGN and DIVO?

IMGN has a forward dividend yield of 6.40% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 0.22 percentage points.

Home › Compare › IMGN vs DIVO

IMGN vs DIVO: Dividend Comparison 2026

IMGN yields 6.40% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DIVO wins by $446.00 in total portfolio value

INVESTMENT

TIME HORIZON10 years

IMGN

● Live price

6.40%

Share price

$31.24

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$962.44

Full IMGN calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — IMGN vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IMGN	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IMGN + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IMGN pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMGN

Annual income on $10K today (after 15% tax)

$544.26/yr

After 10yr DRIP, annual income (after tax)

$818.07/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, DIVO beats the other by $39.13/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMGN + DIVO for your $10,000?

IMGN: 50%DIVO: 50%

100% DIVO50/50100% IMGN

Portfolio after 10yr

$30.8K

Annual income

$985.46/yr

Blended yield

3.20%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on IMGN right now

IMGN

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$14.79

-52.6% upside vs current

Range: $6.36 — $22.00

Altman Z

18.1

Piotroski

3/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMGN buys

DIVO buys

No recent congressional trades found for IMGN or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIMGNDIVO

Forward yield	6.40%	6.62% ✓
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$30.5K	$31.0K ✓
Annual income after 10y	$962.44	$1,008.47 ✓
Total dividends collected	$8.1K	$8.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: IMGN vs DIVO ($10,000, DRIP)

Year	IMGN Portfolio	IMGN Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$11,340	$640.31	$11,362	$661.96	$22.00 → DIVO
2	$12,813	$678.62	$12,860	$702.91	$47.00 → DIVO
3	$14,426	$716.58	$14,504	$743.56	$78.00 → DIVO
4	$16,190	$754.03	$16,303	$783.73	$113.00 → DIVO
5	$18,114	$790.87	$18,268	$823.31	$154.00 → DIVO
6	$20,209	$826.97	$20,408	$862.17	$199.00 → DIVO
7	$22,486	$862.25	$22,737	$900.20	$251.00 → DIVO
8	$24,957	$896.64	$25,266	$937.31	$309.00 → DIVO
9	$27,634	$930.05	$28,008	$973.42	$374.00 → DIVO
10	$30,531	$962.44	$30,977	$1,008.47	$446.00 → DIVO

IMGN vs DIVO: Complete Analysis 2026

IMGN — Stock

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.

Full IMGN Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this IMGN vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMGN vs SCHD IMGN vs JEPI IMGN vs O IMGN vs KO IMGN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.